Artificial intelligence is now built directly into many SaaS platforms, and that shift has created a new testing challenge. These systems don’t just run code, they generate predictions, adapt to fresh ...

Israeli company Irregular, previously known as Pattern Labs, on Wednesday announced raising $80 million for its AI security lab. Founded by Dan Lahav (CEO) and Omer Nevo (CTO), the company has created ...

YouTube announces A/B title testing availability, along with AI-powered conversational analytics for YouTube Studio. Title tests are coming to YouTube Studio 'Ask Studio' lets you query analytics in ...

The Israeli cybersecurity startup plans to expand its offensive security offering to cover more enterprise attack surface. Israeli cybersecurity startup Terra Security today announced raising $30 ...

India’s Hikal Limited has been hit with an FDA warning letter chiding the drug ingredients manufacturer for failing to uncover the cause of dozens of complaints of metal contamination in its products.

A threat actor targeting exposed Docker APIs has updated its malicious tooling with more dangerous functionality that could lay the foundation for a complex botnet. The activity was first reported in ...

SwissBorg, a Switzerland-based crypto wealth management platform, said hackers exploited a vulnerability in the API of its staking partner Kiln, draining about 193,000 Solana tokens from its Earn ...

The Army’s new generational replacement for the M4-style rifles that infantry soldiers have carried into battle for nearly 50 years will receive less independent and real-world testing after it was ...

Kong Inc., a maker of tools for managing application programming interfaces, today said it has acquired OpenMeter, the developer of an open-source platform for usage-based metering and billing. Terms ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

While trade groups hail the executive order as a national health security opportunity, analysts warn that production costs could go up in the near term. Pharma industry trade groups have responded ...